Brey Robert N 4
4 · DOR BIOPHARMA INC · Filed Mar 30, 2009
Insider Transaction Report
Form 4
Brey Robert N
Chief Scientific Officer/SrVP
Transactions
- Award
Stock Options (Right to Buy)
2000-02-08+9,000→ 9,000 totalExercise: $3.94From: 2000-02-08Exp: 2010-02-07→ Common Stock (9,000 underlying) - Award
Stock Options (Right to Buy)
2006-05-10+600,000→ 600,000 totalExercise: $0.33From: 2006-05-10Exp: 2016-05-09→ Common Stock (600,000 underlying) - Award
Stock Options (Right to Buy)
2008-12-18+800,000→ 800,000 totalExercise: $0.06From: 2008-12-18Exp: 2018-12-17→ Common Stock (800,000 underlying) - Award
Stock Options (Right to Buy)
2007-08-10+200,000→ 200,000 totalExercise: $0.47From: 2007-08-10Exp: 2017-08-09→ Common Stock (200,000 underlying)
Footnotes (4)
- [F1]Granted stock options to purchase 9,000 shares of the Company's common stock that vested immediately. The exercise price of the options equals $3.94 per share, the market price of the Company s common stock as of the close of business on February 8, 2000.
- [F2]Granted stock options to purchase 600,000 shares of the Company's common stock, of which 150,000 shares vest immediately and the remainder of the options will vest on each three (3) month anniversary of the grant date at a rate of 37,500 options per quarter. The exercise price of the options equals $0.33 per share, the market price of the Company s common stock as of the close of business on May 10, 2006.
- [F3]Granted stock options to purchase 200,000 shares of the Company's common stock, of which 50,000 shares vest immediately and the remainder of the options will vest on each three (3) month anniversary of the grant date at a rate of 12,500 options per quarter. The exercise price of the options equals $0.47 per share, the market price of the Company's common stock as of the close of business on August 10, 2007.
- [F4]Granted stock options to purchase 800,000 shares of the Company's common stock, of which 200,000 shares vest immediately and the remainder of the options will vest on each three (3) month anniversary of the grant date at a rate of 50,000 options per quarter. The exercise price of the options equals $0.06 per share, the market price of the Company's common stock as of the close of business on December 18, 2008.